Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$0.38.

  • Palisade Bio's EPS (Basic) rose 8362.07% to -$0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.12, marking a year-over-year increase of 8485.71%. This contributed to the annual value of -$10.5 for FY2024, which is 6113.06% up from last year.
  • Latest data reveals that Palisade Bio reported EPS (Basic) of -$0.38 as of Q3 2025, which was up 8362.07% from -$0.58 recorded in Q2 2025.
  • Palisade Bio's EPS (Basic)'s 5-year high stood at $1.87 during Q4 2022, with a 5-year trough of -$12.96 in Q1 2022.
  • Over the past 5 years, Palisade Bio's median EPS (Basic) value was -$3.46 (recorded in 2021), while the average stood at -$3.71.
  • Per our database at Business Quant, Palisade Bio's EPS (Basic) soared by 16363.64% in 2021 and then plummeted by 107619.05% in 2022.
  • Quarter analysis of 5 years shows Palisade Bio's EPS (Basic) stood at $0.42 in 2021, then soared by 345.24% to $1.87 in 2022, then crashed by 301.6% to -$3.77 in 2023, then surged by 36.61% to -$2.39 in 2024, then surged by 84.1% to -$0.38 in 2025.
  • Its EPS (Basic) stands at -$0.38 for Q3 2025, versus -$0.58 for Q2 2025 and -$0.47 for Q1 2025.